Várri Consultancy announces its support to oncology innovation competition

19 November 2026 Consultancy-me.com 2 min. read

EndCancer.Life has opened applications for its Winter Pitch Competition 2027, offering oncology startups and scaleups an opportunity to present their innovations to investors and industry leaders. Várri Consultancy is supporting the initiative as a knowledge partner, with managing director Johnny Kollin also participating as a mentor.

The global competition aims to accelerate innovation in cancer care by connecting promising ventures with the expertise, networks and investment needed to bring new solutions to market.

Five startups and five scaleups will be selected to pitch their innovations live to an audience of investors and corporate leaders. The competition covers innovations in cancer prevention, prediction, diagnostics and treatment. Finalists will be announced in January next year.

The Winter Pitch Competition 2027 is part of EndCancer.Life’s mission to accelerate oncology innovation by bringing together entrepreneurs with investors, corporate leaders, mentors and other specialists.

The need for oncology innovation

The initiative comes amid growing demand for innovation across cancer diagnostics, treatment and patient care. With one in five people worldwide developing cancer during their lifetime, advances in medical research, diagnostics and treatment have the potential to save lives, improve patient outcomes and reduce the burden of cancer on patients and their families.

While advances in biotechnology, artificial intelligence and personalised medicine are creating new opportunities, translating scientific breakthroughs into commercially viable solutions remains a complex process. “Turning a promising idea into a sustainable business requires more than scientific or technological progress,” said Johnny Kollin, Managing Director of Várri Consultancy.

This is where Várri Consultancy aims to contribute. The Dubai-based advisory firm specialises in strategy, risk, governance, investment and business transformation, areas that become increasingly important as emerging ventures mature and seek investment, partnerships and commercial growth.

Part of broader ESG agenda

The partnership also aligns with Várri Consultancy’s broader environmental, social and governance (ESG) commitments, particularly its focus on responsible business conduct and creating sustainable long-term value. The firm joined the UN Global Compact in 2024 and published its 2026 Communication on Progress, outlining its efforts to strengthen governance, ethical business practices and environmental responsibility.

By supporting oncology entrepreneurs, Várri Consultancy is extending this commitment to social impact, contributing its expertise to businesses seeking to improve cancer care and patient outcomes.

Kollin, who is personally participating as a mentor, also highlighted the value of external perspectives in helping entrepreneurs navigate complex decisions. “External expertise cannot replace robust evidence, strong management, or sound judgement. It can, however, bring a fresh perspective to important decisions, challenge assumptions, and help management identify risks and opportunities earlier.”